Orforglipron

Orforglipron (LY3502970)

AI explanation

Orforglipron is essentially a pill version of those popular weight loss injections you've probably heard about, like Ozempic or Wegovy. People are excited about it because it could give you the same appetite-suppressing and blood sugar benefits without having to inject yourself every week – you'd just swallow a pill once a day, anytime you want.

Here's what makes it clever: your digestive system normally destroys the active ingredients in those injection medicines before they can work, which is why they have to be injected. But orforglipron is built differently – it's like a molecular key that's tough enough to survive the acid bath in your stomach and still unlock the same doors in your body.

Once it gets into your system, orforglipron tricks your brain into thinking you're fuller than you actually are, so you naturally eat less without feeling deprived. At the same time, it tells your stomach to slow down how quickly it empties food, keeping you satisfied longer. It also helps your body use insulin more effectively, which keeps your blood sugar steady and reduces those energy crashes that make you crave snacks. Essentially, it rewires your body's hunger and energy systems to work more like they did when you were younger.

Dosage Information

Typical Dose

12-36 mg

Frequency

Once daily

Anytime

Administration

Oral tablet

Half-Life

24–48 hours

Notes

No food timing restrictions. Phase 3 tested 12, 24, and 36 mg doses. FDA submission planned 2026.

Why this matters

Oral non-peptide GLP-1 agonist; once-daily pill replaces weekly injection.

Where does Orforglipron sit?

See how this peptide compares across all 150 peptides in our database.

Potential Side Effects

NauseaVomitingDiarrheaConstipation
Pep Talk

Orforglipron discussions

Quick Facts

Administration
Oral tablet
Typical Dose
12-36 mg
Frequency
Once daily
References
1 curated + 0 from PubMed

Frequently Asked Questions about Orforglipron

What is Orforglipron?

Orforglipron is a non-peptide, oral GLP-1 receptor agonist being developed by Eli Lilly. Unlike injectable GLP-1 drugs, it is a small molecule that survives digestion without special formulation, taken as a once-daily pill with no timing restrictions.

How does Orforglipron work?

Small molecule GLP-1 receptor agonist that activates the same receptor as semaglutide but is not a peptide — it survives the digestive system without modification. Suppresses appetite, slows gastric emptying, and improves insulin sensitivity through the same pathways as injectable GLP-1 drugs.

What is the recommended dosage for Orforglipron?

The typical dose is 12-36 mg. Once daily. Administration: Oral tablet. No food timing restrictions. Phase 3 tested 12, 24, and 36 mg doses. FDA submission planned 2026.

What are the side effects of Orforglipron?

Nausea. Vomiting. Diarrhea. Constipation

Questions reflect common community inquiries. This is not medical advice.